SpineGuard Statistics
Total Valuation
SpineGuard has a market cap or net worth of EUR 6.45 million. The enterprise value is 8.27 million.
Market Cap | 6.45M |
Enterprise Value | 8.27M |
Important Dates
The next estimated earnings date is Wednesday, September 10, 2025.
Earnings Date | Sep 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SpineGuard has 62.98 million shares outstanding. The number of shares has increased by 30.47% in one year.
Current Share Class | 62.98M |
Shares Outstanding | 62.98M |
Shares Change (YoY) | +30.47% |
Shares Change (QoQ) | +12.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.39 |
PB Ratio | 1.65 |
P/TBV Ratio | 14.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.68 |
EV / Sales | 1.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.43 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.65.
Current Ratio | 0.97 |
Quick Ratio | 0.65 |
Debt / Equity | 0.65 |
Debt / EBITDA | n/a |
Debt / FCF | -1.05 |
Interest Coverage | -10.40 |
Financial Efficiency
Return on equity (ROE) is -62.04% and return on invested capital (ROIC) is -24.59%.
Return on Equity (ROE) | -62.04% |
Return on Assets (ROA) | -19.86% |
Return on Invested Capital (ROIC) | -24.59% |
Return on Capital Employed (ROCE) | -60.38% |
Revenue Per Employee | 211,274 |
Profits Per Employee | -140,085 |
Employee Count | 22 |
Asset Turnover | 0.48 |
Inventory Turnover | 1.13 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.70% in the last 52 weeks. The beta is 2.65, so SpineGuard's price volatility has been higher than the market average.
Beta (5Y) | 2.65 |
52-Week Price Change | -48.70% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | 0.18 |
Relative Strength Index (RSI) | 40.35 |
Average Volume (20 Days) | 321,983 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SpineGuard had revenue of EUR 4.65 million and -3.08 million in losses. Loss per share was -0.06.
Revenue | 4.65M |
Gross Profit | 3.63M |
Operating Income | -3.06M |
Pretax Income | -3.08M |
Net Income | -3.08M |
EBITDA | -2.87M |
EBIT | -3.06M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 719,310 in cash and 2.54 million in debt, giving a net cash position of -1.82 million or -0.03 per share.
Cash & Cash Equivalents | 719,310 |
Total Debt | 2.54M |
Net Cash | -1.82M |
Net Cash Per Share | -0.03 |
Equity (Book Value) | 3.90M |
Book Value Per Share | 0.07 |
Working Capital | -108,504 |
Cash Flow
In the last 12 months, operating cash flow was -2.35 million and capital expenditures -61,962, giving a free cash flow of -2.41 million.
Operating Cash Flow | -2.35M |
Capital Expenditures | -61,962 |
Free Cash Flow | -2.41M |
FCF Per Share | -0.04 |
Margins
Gross margin is 78.05%, with operating and profit margins of -65.86% and -66.30%.
Gross Margin | 78.05% |
Operating Margin | -65.86% |
Pretax Margin | -66.30% |
Profit Margin | -66.30% |
EBITDA Margin | -61.83% |
EBIT Margin | -65.86% |
FCF Margin | n/a |
Dividends & Yields
SpineGuard does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -30.47% |
Shareholder Yield | n/a |
Earnings Yield | -47.79% |
FCF Yield | -37.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SpineGuard has an Altman Z-Score of 0.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.3 |
Piotroski F-Score | 3 |